
Please try another search
PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and Full Time Equivalent (FTE). The company also provides small molecule drug substance CDMO services, including optimal route scouting; FFS and FTE for process research and development of RSMs, intermediates, and APIs; impurity studies and synthesis; solid state chemistry; analytical development and quality control; cGMP manufacturing of intermediates and APIs; and CMC regulatory filing support. In addition, it offers small molecule DP CDMO services, such as candidate screening and selection, early development, and full development; and new modality services, including target protein degrader, peptide, oligonucleotide, and ADC services. The company was founded in 2006 and is based in Nanjing, the People's Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Yuanping Jie | 59 | 2016 | Non-Independent Director |
Li Jin | 51 | 2021 | Non-Employee Supervisor & Independent Director |
Minmin Yang | 53 | 2014 | Co-Founder, Chairman & CEO |
Xihe Jiang | 67 | 2024 | Independent Director |
Jie Cai | 44 | 2021 | Supervisor |
Chen Chen | 39 | 2024 | Non-Independent Director |
Shuqiang Zhang | 43 | 2021 | Chairman of the Supervisory Board |
Xiaonan Zheng | 61 | 2024 | Independent Director |
Jin Li | 38 | 2024 | Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review